HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
25 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
SIAH1
siah E3 ubiquitin protein ligase 1
Chromosome 16 Β· 16q12.1
NCBI Gene: 6477Ensembl: ENSG00000196470.13HGNC: HGNC:10857UniProt: Q8IUQ4
200PubMed Papers
21Diseases
0Drugs
19Pathogenic Variants
FUNCTIONAL ROLE
Highly Constrained
RESEARCH IMPACT
Trending
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
ubiquitin-dependent protein catabolic processubiquitin-protein transferase activityprotein bindingzinc ion bindingBuratti-Harel syndromeNeurodevelopmental disorderLaryngomalaciacomplex neurodevelopmental disorder
✦AI Summary

SIAH1 (siah E3 ubiquitin protein ligase 1) is an E3 ubiquitin ligase that plays crucial roles in protein degradation and cellular homeostasis. The protein mediates ubiquitination and proteasomal degradation of numerous substrates by accepting ubiquitin from E2 enzymes and transferring it to target proteins 1. SIAH1 functions through direct substrate binding or as part of larger E3 complexes, targeting proteins involved in transcription regulation, cell signaling, and structural functions 1. The enzyme operates through a novel mechanism where small molecules can induce target protein polymerization, leading to sequestration and subsequent degradation, as demonstrated with BCL6 degradation 1. SIAH1 is involved in critical cellular processes including apoptosis, Wnt signaling through AXIN2 regulation 2, and hypoxia response via HIF-1Ξ± pathway modulation 3. In disease contexts, SIAH1 exhibits dual roles: promoting glioma cell migration and invasion under hypoxic conditions 3, facilitating hepatocellular carcinoma survival through mitophagy regulation 4, and mediating PPARΞ³ degradation in bladder cancer 5. The protein's dysregulation contributes to various pathological conditions, making it a potential therapeutic target for cancer treatment 6. SIAH1's complex regulatory network and diverse substrate specificity highlight its importance in maintaining cellular protein homeostasis.

Sources cited
1
SIAH1 facilitates ubiquitination of BCL6 through drug-induced protein polymerization
PMID: 33208943
2
SIAH1 binds to Axin2-GBD domain and regulates Wnt/Ξ²-catenin signaling pathway
PMID: 37189394
3
SIAH1 promotes glioma cell migration and invasion under hypoxia by regulating HIF-1Ξ± signaling
PMID: 25572001
4
SIAH1 mediates mitophagy in hepatocellular carcinoma and affects sorafenib sensitivity
PMID: 36385558
5
SIAH1/2 mediates proteasomal degradation of PPARΞ³ in luminal bladder cancer
PMID: 39695138
6
SIAH1 functions as both promoter and suppressor in cancer and nervous system diseases
PMID: 34958110
Disease Associationsβ“˜21
Buratti-Harel syndromeOpen Targets
0.68Moderate
Neurodevelopmental disorderOpen Targets
0.44Moderate
LaryngomalaciaOpen Targets
0.37Weak
complex neurodevelopmental disorderOpen Targets
0.37Weak
developmental disabilityOpen Targets
0.37Weak
Floppy infantOpen Targets
0.37Weak
cardiomyopathyOpen Targets
0.32Weak
tooth diseaseOpen Targets
0.32Weak
Abruptio PlacentaeOpen Targets
0.24Weak
genetic disorderOpen Targets
0.18Weak
breast cancerOpen Targets
0.10Suggestive
hepatocellular carcinomaOpen Targets
0.10Suggestive
neoplasmOpen Targets
0.09Suggestive
colorectal carcinomaOpen Targets
0.09Suggestive
gastric cancerOpen Targets
0.08Suggestive
azoospermiaOpen Targets
0.08Suggestive
liver cancerOpen Targets
0.08Suggestive
posterior cortical atrophyOpen Targets
0.07Suggestive
HyperhidrosisOpen Targets
0.07Suggestive
partial chromosome Y deletionOpen Targets
0.06Suggestive
Buratti-Harel syndromeUniProt
Pathogenic Variants19
NM_003031.4(SIAH1):c.455A>G (p.His152Arg)Likely pathogenic
not provided|See cases
β˜…β˜…β˜†β˜†2024β†’ Residue 152
NM_003031.4(SIAH1):c.15_16insA (p.Ala6fs)Likely pathogenic
Buratti-Harel syndrome|See cases
β˜…β˜…β˜†β˜†2024β†’ Residue 6
NM_003031.4(SIAH1):c.23dup (p.Leu9fs)Likely pathogenic
Buratti-Harel syndrome
β˜…β˜†β˜†β˜†2025β†’ Residue 9
NM_003031.4(SIAH1):c.260T>C (p.Met87Thr)Likely pathogenic
SIAH1-related neurodevelopmental disorder
β˜…β˜†β˜†β˜†2025β†’ Residue 87
NM_003031.4(SIAH1):c.140A>G (p.Tyr47Cys)Likely pathogenic
not provided
β˜…β˜†β˜†β˜†2024β†’ Residue 47
NM_003031.4(SIAH1):c.361dup (p.Cys121fs)Likely pathogenic
Buratti-Harel syndrome
β˜…β˜†β˜†β˜†2022β†’ Residue 121
NM_003031.4(SIAH1):c.484G>A (p.Asp162Asn)Likely pathogenic
Buratti-Harel syndrome
β˜…β˜†β˜†β˜†2022β†’ Residue 162
NM_003031.4(SIAH1):c.226C>T (p.Arg76Trp)Likely pathogenic
not provided
β˜…β˜†β˜†β˜†2022β†’ Residue 76
NM_003031.4(SIAH1):c.149C>T (p.Pro50Leu)Likely pathogenic
Buratti-Harel syndrome|Neurodevelopmental disorder
β˜…β˜†β˜†β˜†2021β†’ Residue 50
NM_003031.4(SIAH1):c.165T>A (p.Cys55Ter)Likely pathogenic
See cases
β˜…β˜†β˜†β˜†β†’ Residue 55
NM_003031.4(SIAH1):c.19dup (p.Thr7fs)Likely pathogenic
See cases
β˜…β˜†β˜†β˜†β†’ Residue 7
NM_003031.4(SIAH1):c.71_75del (p.Ala24fs)Likely pathogenic
See cases
β˜…β˜†β˜†β˜†β†’ Residue 24
NM_003031.4(SIAH1):c.104T>A (p.Leu35Ter)Likely pathogenic
See cases
β˜…β˜†β˜†β˜†β†’ Residue 35
NM_003031.4(SIAH1):c.337_338del (p.Glu113fs)Likely pathogenic
See cases
β˜…β˜†β˜†β˜†β†’ Residue 113
NM_003031.4(SIAH1):c.502A>G (p.Thr168Ala)Pathogenic
Buratti-Harel syndrome
β˜†β˜†β˜†β˜†2021β†’ Residue 168
NM_003031.4(SIAH1):c.383G>T (p.Cys128Phe)Pathogenic
Buratti-Harel syndrome
β˜†β˜†β˜†β˜†2021β†’ Residue 128
NM_003031.4(SIAH1):c.121T>G (p.Cys41Gly)Pathogenic
Buratti-Harel syndrome
β˜†β˜†β˜†β˜†2021β†’ Residue 41
NM_003031.4(SIAH1):c.520G>C (p.Gly174Arg)Pathogenic
Buratti-Harel syndrome
β˜†β˜†β˜†β˜†2021β†’ Residue 174
NM_003031.4(SIAH1):c.288C>G (p.Phe96Leu)Likely pathogenic
Buratti-Harel syndrome
β˜†β˜†β˜†β˜†β†’ Residue 96
View on ClinVar β†—
Related Genes
AXIN1Protein interaction100%FBXO45Protein interaction100%SNCAProtein interaction100%CTNNB1Protein interaction100%CSNK1A1Protein interaction99%UBE2D2Protein interaction99%
Tissue Expression6 tissues
Bone Marrow
100%
Brain
83%
Liver
50%
Ovary
42%
Lung
36%
Heart
36%
Gene Interaction Network
Click a node to explore
SIAH1AXIN1FBXO45SNCACTNNB1CSNK1A1UBE2D2
PROTEIN STRUCTURE
Preparing viewer…
PDB4CA1 Β· 1.58 Γ… Β· X-ray
View on RCSB β†—
Constraintβ“˜
LOEUFβ“˜
0.30Highly Constrained
pLIβ“˜
1.00Intolerant
Observed/Expected LoF0.09 [0.04–0.30]
RankingsWhere SIAH1 stands among ~20K protein-coding genes
  • #2,115of 20,598
    Most Researched200 Β· top quartile
  • #2,221of 5,498
    Most Pathogenic Variants19
  • #1,123of 17,882
    Most Constrained (LOEUF)0.30 Β· top 10%
Genes detectedSIAH1
Sources retrieved25 papers
Response timeβ€”
πŸ“„ Sources
25β–Ό
1
Small-molecule-induced polymerization triggers degradation of BCL6.
PMID: 33208943
Nature Β· 2020
1.00
2
Organelle-specific autophagy in inflammatory diseases: a potential therapeutic target underlying the quality control of multiple organelles.
PMID: 32048886
Autophagy Β· 2021
0.90
3
The landscape of genetic diseases in Saudi Arabia based on the first 1000 diagnostic panels and exomes.
PMID: 28600779
Hum Genet Β· 2017
0.80
4
Deficiency of SIAH1 promotes the formation of filopodia by increasing the accumulation of FASN in liver cancer.
PMID: 39075049
Cell Death Dis Β· 2024
0.72
5
Siah1 in cancer and nervous system diseases (Review).
PMID: 34958110
Oncol Rep Β· 2022
0.70